COLOGUARD ADHERENCE

The Cologuard® test has demonstrated improved screening rates among previously nonadherent average-risk patients1

In a retrospective EHR-based medical record review from October 2014 to September 2015, 77 primary care physicians offered the Cologuard test to 393 patients on Medicare who were nonadherent with CRC screening recommendations. Descriptive statistics were used.1
0%

Adherence

0 of 393 patients were adherent with recommended CRC screening1

88.3%

Cologuard adherence

88.3% of previously nonadherent patients were adherent with the Cologuard test over 12 months1

96.1%

Follow-up colonoscopy

96.1% of patients with a positive Cologuard result underwent a follow-up colonoscopy1*

Study limitations: A relatively small study size from a single health center; findings may not be generalizable to patients not on Medicare or to patients outside this particular geographic area (Dallas, TX). No formal hypothesis testing was done, therefore unable to determine causality.1

Dr Timothy Quinn discusses the Cologuard impact on CRC screening rates in his practice

The Impact of the Cologuard Test on CRC Screening Adherence

Learn more with Dr Quinn and other providers.

Cologuard box.

Better outcomes with the Cologuard test

View the impact of a positive Cologuard result on follow-up colonoscopies.

Explore Results
optimize your experience
Which colorectal cancer (CRC) screening option do you prescribe most often to your average-risk patients starting at 45?
Your most prescribed CRC screening option:
Change answer

Cologuard adherence is supported by its patient navigation program2

Outreach through the patient navigation program resulted in a 22% point increase in Cologuard adherence vs Cologuard patients who did not receive outreach.2†

Man holding a Cologuard box on his side.
The Cologuard patient navigation program provides encouragement for patients throughout the screening process.
Learn More

Repeat screening with the Cologuard test

Discover adherence rates when screening every 3 years

Learn more
  • * Multitarget stool DNA test was positive in 51 patients. Follow-up colonoscopy was carried out in 49 positive patients, with 2 patients lost to follow-up.1
  • † Compared with a small control sample of eligible patients who do not receive outreach from the patient navigation program for evaluating program effectiveness.2